早期卵巢衰老:年轻女性取卵数少是否与年龄相关疾病风险提前和增加有关?
这项基于注册库的全国性历史队列研究纳入1995-2014年间首次接受ART治疗的≤37岁女性,比较早期卵巢衰老(EOA,n=1222)与正常卵巢衰老(NOA,n=16385)的年龄相关事件风险。EOA组年龄相关事件风险升高(校正HR 1.24,95%CI 1.08-1.43),心血管疾病(HR 1.44,95%CI 1.19-1.75)和骨质疏松(HR 2.45,95%CI 1.59-3.90)风险显著增加。
要点
- 年轻女性ART中反复取卵少(EOA)与年龄相关事件风险升高相关(校正HR 1.24,95%CI 1.08-1.43)。
- EOA组心血管疾病风险显著升高(HR 1.44,95%CI 1.19-1.75)。
- EOA组骨质疏松风险显著升高(HR 2.45,95%CI 1.59-3.90)。
核心结论
- 随访时,特发性EOA女性年龄相关事件风险高于NOA女性。
- 取卵数可能作为年轻女性日后加速衰老的标志。
- 作者认为对该组女性进行生活方式咨询作为预防心血管和其他年龄相关疾病的努力可能至关重要。
研究设计与样本
- 基于注册库的全国性历史队列研究。
- 纳入1995-2014年间在公立或私立生育诊所首次接受ART治疗的≤37岁女性。
- EOA组n=1222,NOA组n=16385。
- EOA定义为至少两个FSH刺激周期中取卵≤5个,NOA定义为至少一个周期取卵≥8个。
- 排除已知影响卵巢储备的病例(子宫内膜异位症、卵巢手术、多囊卵巢综合征、化疗等)。
主要发现
- EOA组从基线至首次事件的中位随访时间4.9年(10/90百分位0.7/11.8),NOA组6.4年(1.1/13.3)。
- EOA组年龄相关事件校正HR 1.24(95%CI 1.08-1.43)。
- EOA组心血管疾病HR 1.44(95%CI 1.19-1.75),骨质疏松HR 2.45(95%CI 1.59-3.90)。
- Charlson合并症指数HR 1.15(95%CI 0.93-1.41)和提前退休福利HR 1.21(95%CI 0.80-1.83)虽升高但未达统计学显著。
关键数值与推荐
- 主要结局为年龄相关事件的总体风险,定义为诊断为心血管疾病、骨质疏松、2型糖尿病、癌症、白内障、阿尔茨海默病或帕金森病之一,或任何原因死亡,或Charlson合并症指数评分≥1,或登记提前退休福利。
- 采用Cox回归模型评估风险。
- 暴露状态在首次ART周期后1年定义,事件时间从该时间点起测。
临床怎么用
- 作者认为取卵数可能作为年轻女性意外反复取卵少时日后加速衰老的标志。
- 作者认为对该组女性进行生活方式咨询作为预防心血管和其他年龄相关疾病的努力可能至关重要。
局限性
- 从未达到卵母细胞抽吸的周期未纳入考虑,因此可能遗漏了最严重形式的EOA女性。
- 没有每个周期促性腺激素总剂量的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do young women with early ovarian ageing (EOA), defined as unexplained, and repeatedly few oocytes harvested in ART have an increased risk of age-related events? SUMMARY ANSWER: At follow-up, women with idiopathic EOA had an increased risk of age-related events compared to women with normal ovarian ageing (NOA). WHAT IS KNOWN ALREADY: Early and premature menopause is associated with an increased risk of cardiovascular diseases (CVDs), osteoporosis and death. In young women, repeated harvest of few oocytes in well-stimulated ART cycles is a likely predictor of advanced menopausal age and may thus serve as an early marker of accelerated general ageing. STUDY DESIGN, SIZE, DURATION: A register-based national, historical cohort study. Young women (≤37 years) having their first ART treatment in a public or private fertility clinic during the period 1995-2014 were divided into two groups depending on ovarian reserve status: EOA (n = 1222) and NOA (n = 16 385). Several national registers were applied to assess morbidity and mortality. PARTICIPANTS/MATERIALS, SETTING, METHODS: EOA was defined as ≤5 oocytes harvested in a minimum of two FSH-stimulated cycles and NOA as ≥8 oocytes in at least one cycle. Cases with known causes influencing the ovarian reserve (endometriosis, ovarian surgery, polycystic ovary syndrome, chemotherapy etc.) were excluded. To investigate for early signs of ageing, primary outcome was an overall risk of ageing-related events, defined as a diagnosis of either CVD, osteoporosis, type 2 diabetes, cancer, cataract, Alzheimer's or Parkinson's disease, by death of any-cause as well as a Charlson comorbidity index score of ≥1 or by registration of early retirement benefit. Cox regression models were used to assess the risk of these events. Exposure status was defined 1 year after the first ART cycle to assure reliable classification, and time-to-event was measured from that time point. MAIN RESULTS AND THE ROLE OF CHANCE: Median follow-up time from baseline to first event was 4.9 years (10/90 percentile 0.7/11.8) and 6.4 years (1.1/13.3) in the EOA and NOA group, respectively. Women with EOA had an increased risk of ageing-related events when compared to women with a normal oocyte yield (adjusted hazard ratio 1.24, 95% CI 1.08 to 1.43). Stratifying on categories, the EOA group had a significantly increased risk for CVD (1.44, 1.19 to 1.75) and osteoporosis (2.45, 1.59 to 3.90). Charlson comorbidity index (1.15, 0.93 to 1.41) and early retirement benefit (1.21, 0.80 to 1.83) was also increased, although not reaching statistical significance. LIMITATIONS, REASONS FOR CAUTION: Cycles never reaching oocyte aspiration were left out of account in the inclusion process and we may therefore have missed women with the most severe forms of EOA. We had no information on the total doses of gonadotrophin administered in each cycle. WIDER IMPLICATIONS OF THE FINDINGS: These findings indicate that oocyte yield may serve as marker of later accelerated ageing when, unexpectedly, repeatedly few oocytes are harvested in young women. Counselling on life-style factors as a prophylactic effort against cardiovascular and other age-related diseases may be essential for this group of women. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Christensen MW, Kesmodel US, Christensen K, et al. Early ovarian ageing: is a low number of oocytes harvested in young women associated with an earlier and increased risk of age-related diseases? Hum Reprod. 2020. PMID: 32949236. doi:10.1093/humrep/deaa188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。